There are 702 resources available
379P - The role of lymphocyte to monocyte ratio as a prognostic index to predict poor prognosis in patients with unresectable pancreatic cancer treated with chemotherapy
Presenter: Waleed Arafat
Session: Poster Display session
380P - Understanding the burden and mental health of informal caregivers for stomach and pancreatic cancer patients
Presenter: Mohit Pandey
Session: Poster Display session
381P - Evaluation of the prognostic impact of circulating free tumor DNA (cftDNA) dynamics in borderline resectable (BR) or locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)
Presenter: Giada Grelli
Session: Poster Display session
382P - Gut microbiome profiles as a novel predictor of tumor response to chemotherapy in pancreatic cancer patients
Presenter: Juliana de Castilhos
Session: Poster Display session
383P - ctDNA response evaluation criteria in metastatic pancreatic cancer using aberrant methylation test
Presenter: Karen-Lise Spindler
Session: Poster Display session
384P - Predictive value of Gal1 and sAxL plasma levels in chemotherapy response of pancreatic ductal adenocarcinoma patients
Presenter: Laura Visa Turmo
Session: Poster Display session
385P - Effect of PRMT1 and ZEB1 expression on first-line FOLFIRINOX chemotherapy response in patients with locally advanced or metastatic pancreatic cancer
Presenter: Cansu Coskun Gençalp
Session: Poster Display session
386P - Exploratory biomarker analysis based on the PREDICT trial (AIO-PAK-0216) for response prediction to second-line nal-IRI/5-FU/FA chemotherapy (CTX) in metastatic PDAC patients (mPDAC Pts)
Presenter: Anton Lahusen
Session: Poster Display session
387P - The effect of TRPS1 expression on adjuvant gemcitabine efficacy in resected pancreatic cancer
Presenter: Michael Günther
Session: Poster Display session
388P - Characterization of surface proteome of small extracellular vesicles: A novel approach to develop liquid biopsy for pancreatic cancer
Presenter: Ravi Kumar Paluri
Session: Poster Display session